LivingGLP1
Study S001066

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

ClinicalTrials.gov record

Registration

Registration
NCT06217848
Study type
INTERVENTIONAL
Phase
EARLY_PHASE1
Masking
NONE
Status
UNKNOWN
Enrollment
50
Start
2022-11-28
Primary completion
2024-02-08
Lead sponsor
Seoul National University Hospital
Conditions
Panhypopituitarism; Craniopharyngioma; Hypothalamic Obesity
Interventions
DRUG:Saxenda
Results posted
FALSE

Registered primary outcomes

  • Change in weight [3 month]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.